Charles Schwab Investment Management Inc 89bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 629,233 shares of ETNB stock, worth $5.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
629,233
Previous 499,353
26.01%
Holding current value
$5.04 Million
Previous $5.58 Million
31.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ETNB
# of Institutions
164Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$101 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$59.1 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$53.2 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$50.4 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$44.4 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $372M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...